NorthRock Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
VCM
VPM
NorthRock Partners's LH Position: Q1 2026 in Review
NorthRock Partners increased its Labcorp (LH) stake by 5.1% in Q1 2026, buying an estimated $26K and bringing the position to 1,967 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #407.
NorthRock Partners first reported a position in LH in Q2 2025 and has held it in 4 quarters since. The position peaked at $813K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- NorthRock Partners held 1,967 shares of Labcorp worth $525K as of Q1 2026.
- NorthRock Partners bought 96 Labcorp shares in Q1 2026, an estimated $26K.
- Labcorp made up 0.01% of NorthRock Partners's portfolio in Q1 2026, its #407 holding.
- NorthRock Partners first reported a position in Labcorp in Q2 2025 and has held it in 4 quarters since.
- NorthRock Partners's Labcorp position peaked at $813K in Q3 2025.
- 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.